Ekso Bionics (NASDAQ:EKSO) Share Price Passes Below Fifty Day Moving Average of $1.65

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO)’s stock price passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $1.65 and traded as low as $1.40. Ekso Bionics shares last traded at $1.44, with a volume of 162,174 shares.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. StockNews.com raised Ekso Bionics from a “sell” rating to a “hold” rating in a report on Thursday, April 4th. HC Wainwright cut their price target on shares of Ekso Bionics from $10.00 to $9.25 and set a “buy” rating for the company in a research note on Tuesday, March 5th.

Ekso Bionics Stock Down 3.8 %

The stock has a market cap of $22.91 million, a P/E ratio of -1.16 and a beta of 1.61. The firm has a 50 day simple moving average of $1.62 and a 200-day simple moving average of $1.59. The company has a quick ratio of 1.87, a current ratio of 2.49 and a debt-to-equity ratio of 0.38.

Ekso Bionics (NASDAQ:EKSO) last posted its quarterly earnings results on Monday, March 4th. The company reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.11). Ekso Bionics had a negative net margin of 83.14% and a negative return on equity of 90.80%. The business had revenue of $4.85 million during the quarter, compared to the consensus estimate of $4.80 million. During the same quarter last year, the company posted ($0.24) EPS. On average, equities research analysts forecast that Ekso Bionics Holdings, Inc. will post -0.49 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Ekso Bionics

Several hedge funds have recently bought and sold shares of EKSO. Dimensional Fund Advisors LP acquired a new position in shares of Ekso Bionics in the third quarter valued at approximately $28,000. Strategic Wealth Investment Group LLC boosted its stake in Ekso Bionics by 25.8% in the 3rd quarter. Strategic Wealth Investment Group LLC now owns 42,665 shares of the company’s stock valued at $31,000 after purchasing an additional 8,752 shares during the period. Renaissance Technologies LLC grew its holdings in Ekso Bionics by 153.4% in the 2nd quarter. Renaissance Technologies LLC now owns 44,606 shares of the company’s stock valued at $74,000 after buying an additional 27,006 shares in the last quarter. Finally, Kent Lake Capital LLC bought a new position in Ekso Bionics during the 4th quarter worth $353,000. 6.42% of the stock is currently owned by institutional investors and hedge funds.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.